FindTrial
Sign In

CLINICAL TRIAL TO KNOW MOST COMMON SPECIES OF FUNGUS CAUSING SUPERFICIAL FUNGAL INFECTION IN PATIENTS AND TO TEST ACTIVITY OF VARIOUS ANTIFUNGAL DRUGS AGAINST THEM IN LABORATORY

OPEN LABEL, NON RANDOMIZED STUDY OF FUNGAL CULTURE AND IN-VITRO SENSITIVITY TESTING OF VARIOUS TOPICAL AND ORAL ANTIFUNGAL DRUGS IN PATIENTS WITH SUPERFICIAL FUNGAL INFECTION. - NA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2013/09/004025
Enrollment
100
Registered
2013-09-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- SUPERFICIAL FUNGAL INFECTION

Interventions

Intervention1: FUNGAL CULTURE AND SENSITIVITY: SCRAPPING TAKEN FROM THE EDGE OF LESION OF SUPERFICIAL FUNGAL INFECTION WILL BE USED FOR FUNGAL CULTURE AND SENSITIVITY STUDY ACCORDING TO THE STANDARD M

Sponsors

GCS MEDICAL COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Any patients with superficial fungal infection. 2. Patients between the ages of 18yr to 70 yr. 3. Non pregnant non lactating mothers.

Exclusion criteria

Exclusion criteria: 1. Patient who took any oral antifungal drugs in last 3 months. 2. Patients who took any topical medication like- antifungal, steroids etc. in past 1 month. 3. Patients who are on oral immunosuppressive drugs for more than last 15 days. 4. Patients below the age of 18 yr and above the age of 70 yr. 5. Patients who are not willing to sign informed consent form.

Design outcomes

Primary

MeasureTime frame
1.FUNGAL SPECIES IDENTIFIED FROM INDIVIDUAL SAMPLE 2.MINIMUM INHIBITORY CONCENTRATION OF ANTIFUNGALS FOR GROWTHTimepoint: 8 WEEK—

Secondary

MeasureTime frame
1.MOST COMMON SPECIES OF FUNGUS IDENTIFIED FROM ALL SAMPLE TESTED. 2.MYCOLOGICAL CURE RATE PROVEN BY FUNGAL CLEARANCE ON CULTURE Timepoint: 8 WEEK—

Countries

India

Contacts

Public ContactNAYANKUMAR HARSHADKUMAR PATEL

GCS MEDICAL COLLGE

patelnayan78.np@gmail.com9925011309

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026